Agrylin

Agrylin Warnings and Precautions

• Severe bleeding: Agrylin can increase the risk of severe bleeding, which can be fatal.
• Pulmonary hypertension: Agrylin may cause pulmonary hypertension, a form of high blood pressure affecting the arteries between the heart and lungs.
• Cardiovascular effects: Palpitations and rapid heartbeat may occur, particularly in patients with pre-existing heart disease.
• Hepatic impairment: Drug exposure increases substantially in patients with moderate liver impairment, requiring dose reduction and closer monitoring.

How to Access Agrylin in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Agrylin to India?

Agrylin (anagrelide hydrochloride) capsules may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified doctor
• The patient's diagnostic reports, including platelet count
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Agrylin available in India?

Agrylin (anagrelide hydrochloride capsules) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Agrylin is not commercially marketed in India.

However, patients in India can legally access Agrylin through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of a specific patient for their personal treatment, under a valid prescription.

Agrylin received US FDA approval in 1997, ensuring full transparency throughout the process.

Agrylin can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

Sourcing & Delivery

NamedPatientProgram.com (NPP) can source Agrylin from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. Agrylin capsules should be stored at room temperature, 15°C to 30°C, protected from light, and are handled under temperature-controlled shipping conditions throughout transit. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Agrylin cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Agrylin Across Major Cities in India

Patients across India can access Agrylin through regulated import pathways, with delivery arranged to the treating hospital based on a valid hematologist's prescription.

Mumbai

A major hematology hub with institutions like Tata Memorial, Mumbai coordinates access to platelet-lowering therapies like Agrylin for eligible patients.

Delhi

As part of the Delhi NCR region, the city has a strong concentration of hematology specialists, making it a key location for accessing myeloproliferative disorder treatments.

Bangalore

With a growing network of multispecialty hospitals, Bangalore supports access to Agrylin through structured import pathways guided by treating specialists.

Chennai

Home to several reputed hematology centers, Chennai facilitates access to Agrylin for patients with essential thrombocythemia.

Hyderabad

A growing hub for specialty care, Hyderabad supports coordinated access to Agrylin for eligible patients under specialist supervision.

Kolkata

Eastern India's leading medical centers in Kolkata coordinate Agrylin access for patients with elevated platelet counts.

Pune

With an expanding base of hematology clinics, Pune facilitates timely access to Agrylin under prescription.

Ahmedabad

Gujarat's leading hospitals support regulated access to Agrylin for eligible patients.

Kochi

Kerala's healthcare network, including major hospitals in Kochi, coordinates access to platelet-lowering therapies like Agrylin.

Chandigarh

Serving North India, Chandigarh's specialist centers facilitate access to Agrylin for patients from Punjab, Haryana, and Himachal Pradesh.

Jaipur

Rajasthan's leading hospitals support patient access to Agrylin through the Named Patient Program.

Lucknow

A key referral center for North India, Lucknow facilitates coordinated access to Agrylin under specialist care.

Bhubaneswar

Odisha's growing specialty healthcare sector supports patient access to Agrylin.

Guwahati

As a referral hub for the North-East, Guwahati facilitates access to Agrylin for patients across the region.

Access can also be coordinated for patients in other major Indian cities, subject to a valid prescription and regulatory requirements.